NEW YORK, NY / ACCESSWIRE / November 9, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.
Nano-X Imaging Ltd. (NASDAQ:NNOX)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/nano-x-imaging-ltd-loss-submission-form?prid=10807&wire=1
Lead Plaintiff Deadline: November 16, 2020
Class Period: August 21, 2020 - September 15, 2020
Allegations against NNOX include that: (1) Nano-X's commercial agreements and its customers were fabricated; (2) Nano-X's statements regarding its "novel" Nanox System were misleading as the Company never provided data comparing its images with images from competitors' machines; (3) Nano-X's submission to the U.S. Food and Drug Administration admitted the Nanox System was not original; and (4) as a result, Defendants' public statements were materially false and/or misleading at all relevant times.
Odonate Therapeutics, Inc. (NASDAQ:ODT)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/odonate-therapeutics-inc-loss-submission-form?prid=10807&wire=1
Lead Plaintiff Deadline: November 16, 2020
Class Period: December 7, 2017 - April 21, 2020
Allegations against ODT include that: (i) the Company's orally administered chemotherapy agent, tesetaxel, was not as safe or well-tolerated as the Company had led investors to believe; (ii) consequently, tesetaxel's commercial viability as a cancer treatment was overstated; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.
Las Vegas Sands Corp. (NYSE:LVS)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/las-vegas-sands-corp-loss-submission-form?prid=10807&wire=1
Lead Plaintiff Deadline: December 21, 2020
Class Period: February 27, 2016 - September 15, 2020
Allegations against LVS include that: (i) weaknesses existed in Marina Bay Sands' casino control measures pertaining to fund transfers; (ii) the Marina Bay Sands' casino was consequently prone to illicit fund transfers that implicated, among other issues, the transfer of customer funds to unauthorized persons and potential breaches in the Company's anti-money laundering procedures; (iii) the foregoing foreseeably increased the risk of litigation against the Company, as well as investigation and increased oversight by regulatory authorities; (iv) Las Vegas Sands had inadequate disclosure controls and procedures; (v) consequently, all the foregoing issues were untimely disclosed; and (vi) as a result, the Company's public statements were materially false and misleading at all relevant times.
To learn more contact Vincent Wong, Esq. either via email [email protected] or by telephone at 212.425.1140.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: [email protected]
SOURCE: The Law Offices of Vincent Wong